603077 和邦生物
已收盘 09-30 15:00:00
资讯
新帖
简况
和邦生物:公司目前生产经营正常
证券之星 · 09-30 16:00
和邦生物:公司目前生产经营正常
和邦生物(603077)披露2026年半年度业绩说明会安排,9月24日股价下跌1.33%
证券之星 · 09-24
和邦生物(603077)披露2026年半年度业绩说明会安排,9月24日股价下跌1.33%
和邦生物:公司已形成多元化的产业布局
证券之星 · 09-18
和邦生物:公司已形成多元化的产业布局
和邦生物:2026年上半年净利润3.80亿元,同比增长634.30%
证券之星 · 09-18
和邦生物:2026年上半年净利润3.80亿元,同比增长634.30%
和邦生物:截至2026年半年报披露日,和邦生物(香港)投资有限公司持有AEV的股权比例上升至60%
证券之星 · 09-18
和邦生物:截至2026年半年报披露日,和邦生物(香港)投资有限公司持有AEV的股权比例上升至60%
和邦生物:公司目前不涉及玻璃纤维(玻纤)产品
证券之星 · 09-18
和邦生物:公司目前不涉及玻璃纤维(玻纤)产品
每周股票复盘:和邦生物(603077)总经理变更及控股股东质押动态
证券之星 · 09-13
每周股票复盘:和邦生物(603077)总经理变更及控股股东质押动态
和邦生物:现有双甘膦产能20万吨/年,草甘膦产能6万吨/年
证券之星 · 09-11
和邦生物:现有双甘膦产能20万吨/年,草甘膦产能6万吨/年
和邦生物:不存在规避监管或税务义务的情形
证券之星 · 09-11
和邦生物:不存在规避监管或税务义务的情形
和邦生物(603077)披露控股股东部分股份解除质押及再质押公告,9月10日股价下跌3.91%
证券之星 · 09-10
和邦生物(603077)披露控股股东部分股份解除质押及再质押公告,9月10日股价下跌3.91%
异动快报:和邦生物(603077)9月8日10点54分触及涨停板
证券之星 · 09-08
异动快报:和邦生物(603077)9月8日10点54分触及涨停板
每周股票复盘:和邦生物(603077)为子公司提供2亿元担保
证券之星 · 09-06
每周股票复盘:和邦生物(603077)为子公司提供2亿元担保
和邦生物(603077)股东四川和邦投资集团有限公司质押2.07亿股,占总股本2.34%
证券之星 · 09-04
和邦生物(603077)股东四川和邦投资集团有限公司质押2.07亿股,占总股本2.34%
和邦生物:2026年上半年净利润3.80亿元
证券之星 · 09-04
和邦生物:2026年上半年净利润3.80亿元
和邦生物:公司员工持股计划严格依法依规制定
证券之星 · 09-04
和邦生物:公司员工持股计划严格依法依规制定
和邦生物:不存在“机构协议接盘”安排
证券之星 · 09-04
和邦生物:不存在“机构协议接盘”安排
股市必读:和邦生物新发布《和邦生物关于提供担保的进展公告》
证券之星 · 09-03
股市必读:和邦生物新发布《和邦生物关于提供担保的进展公告》
和邦生物(603077)披露关于提供担保的进展公告,9月1日股价上涨2.1%
证券之星 · 09-01
和邦生物(603077)披露关于提供担保的进展公告,9月1日股价上涨2.1%
和邦生物(603077)披露集中竞价减持已回购股份达1%暨减持结果公告,8月31日股价下跌2.46%
证券之星 · 08-31
和邦生物(603077)披露集中竞价减持已回购股份达1%暨减持结果公告,8月31日股价下跌2.46%
和邦生物:公司目前生产经营正常
证券之星 · 08-31
和邦生物:公司目前生产经营正常
加载更多
公司概况
公司名称:
四川和邦生物科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2012-07-31
主营业务:
四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是磷矿、盐矿、联碱产品、双甘膦、草甘膦、二乙腈、蛋氨酸、智能玻璃、光伏玻璃及组件、硅片、农药产品,光伏工程建设、天然气管道运输及转供、成品油销售。
发行价格:
17.50
{"stockData":{"symbol":"603077","market":"SH","secType":"STK","nameCN":"和邦生物","latestPrice":2.19,"timestamp":1790751600000,"preClose":2.18,"halted":0,"volume":68285929,"delay":0,"changeRate":0.0046,"floatShares":8832000000,"shares":8832000000,"eps":-0.0236,"marketStatus":"已收盘","change":0.01,"latestTime":"09-30 15:00:00","open":2.18,"high":2.2,"low":2.17,"amount":149000000,"amplitude":0.0138,"askPrice":2.2,"askSize":31358,"bidPrice":2.19,"bidSize":26257,"shortable":0,"etf":0,"ttmEps":-0.0236,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":2.18,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":2.4,"lowLimit":1.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":8831762228,"isCdr":false,"pbRate":1.02,"roa":"--","roe":"2.08%","epsLYR":-0.0672,"committee":0.279057,"marketValue":19342000000,"turnoverRate":0.0077,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-10-08。","floatMarketCap":19342000000},"requestUrl":"/m/hq/s/603077","defaultTab":"news","newsList":[{"id":"2671711032","title":"和邦生物:公司目前生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2671711032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671711032?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:00","pubTimestamp":1790755243,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问:和邦生物这波短期看到1.8附近止跌,长期看到1.6附近,可对?和邦生物回复:尊敬的投资者您好,二级市场股价受行业周期、公司经营及市场情绪等多重因素影响,具体走势由市场决定,关于您提及的具体股价点位,公司不予评价。公司目前生产经营正常,相关经营信息请以后续公司定期报告及公告内容披露为准。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0229","BK0132","BK0027","BK0196","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196496","title":"和邦生物(603077)披露2026年半年度业绩说明会安排,9月24日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669196496?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:07","pubTimestamp":1790258868,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘,和邦生物报收于2.22元,较前一交易日下跌1.33%,最新总市值为196.07亿元。该股当日开盘2.24元,最高2.26元,最低2.21元,成交额达1.86亿元,换手率为0.95%。公告显示,公司将于2026年10月12日13:00-14:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会,介绍公司经营成果及财务状况。投资者可于2026年9月28日至10月9日16:00前通过上证路演中心网站或公司邮箱jsy@hebang.cn提交问题。说明会后可通过该平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400040801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","603077","BK0229","BK0027","BK0196","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668941775","title":"和邦生物:公司已形成多元化的产业布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2668941775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668941775?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:15","pubTimestamp":1789722946,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物09月18日在投资者关系平台上答复投资者关心的问题。公司历经多年发展,已形成多元化的产业布局,在农药、化肥等业务板块均具备深厚的产业基础和行业影响力,旗下产品在业内具有良好的口碑和品牌认知度,整体体量及综合实力在行业中占据重要地位。2026年上半年,公司实现归属于上市公司股东的净利润3.80亿元,同比增长634.30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800026648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0077","BK0027","BK0132","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668394103","title":"和邦生物:2026年上半年净利润3.80亿元,同比增长634.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668394103","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668394103?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:15","pubTimestamp":1789722945,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物09月18日在投资者关系平台上答复投资者关心的问题。同行业企业营收在增加,和邦生物营收在减少,上半年产品涨价后营收下降更反映出销量在下降,是不是产品订单在流失?目前,公司各项生产经营活动均正常有序开展,与核心客户的合作关系保持稳定。2026年上半年,公司实现归属于上市公司股东的净利润3.80亿元,同比增长634.30%,整体盈利能力明显提高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800026645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668941742","title":"和邦生物:截至2026年半年报披露日,和邦生物(香港)投资有限公司持有AEV的股权比例上升至60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668941742","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668941742?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:15","pubTimestamp":1789722944,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)09月18日在投资者关系平台上答复投资者关心的问题。投资者提问:AEV 公司增资扩股进展是不是不太顺利?已经延期两次了,大股东有什么想法?和邦生物回复:尊敬的投资者您好,AEV为在澳大利亚证券交易所上市的公司,其增资扩股相关事项的决策与披露均以AEV的公告为准。公司作为AEV的股东,长期关注并支持Wonarah项目的开发与推进,截至公司2026年半年报披露日,和邦生物(香港)投资有限公司持有AEV的股权比例上升至60%,AEV成为公司的控股子公司。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800026640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0077","BK0027","BK0196","603077","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668941793","title":"和邦生物:公司目前不涉及玻璃纤维(玻纤)产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2668941793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668941793?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:15","pubTimestamp":1789722924,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)09月18日在投资者关系平台上答复投资者关心的问题。投资者提问:和邦生物有玻璃玻纤产品吗?和邦生物回复:尊敬的投资者您好,公司目前不涉及玻璃纤维(玻纤)产品。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800026635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0077","BK0027","BK0132","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667633500","title":"每周股票复盘:和邦生物(603077)总经理变更及控股股东质押动态","url":"https://stock-news.laohu8.com/highlight/detail?id=2667633500","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667633500?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:20","pubTimestamp":1789240821,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,和邦生物报收于2.37元,较上周的2.3元上涨3.04%。和邦生物关于控股股东部分股份解除质押及部分股份质押的公告四川和邦生物科技股份有限公司控股股东和邦集团持有公司股份1,963,779,103股,占总股本22.24%。截至公告日,和邦集团累计质押股份数量为1,279,000,000股,占其持股总数65.13%,占公司总股本14.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0229","BK0027","BK0196","BK0132","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666228525","title":"和邦生物:现有双甘膦产能20万吨/年,草甘膦产能6万吨/年","url":"https://stock-news.laohu8.com/highlight/detail?id=2666228525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666228525?lang=zh_cn&edition=full","pubTime":"2026-09-11 18:18","pubTimestamp":1789121908,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问:和邦生物草甘膦和双甘膦现有产能和在建产能一共有多少?分别有多少?在建产能根据实际建设情况预测什么时候能投产?和邦生物回复:尊敬的投资者您好,公司现有双甘膦产能20万吨/年,草甘膦产能6万吨/年;在建产能包括广安必美达年产50万吨双甘膦项目、印尼年产35万吨草甘膦项目,两项目当前整体工程进度符合预期,根据公司目前的工程计划,年产50万吨双甘膦项目拟于2027年10月建设完毕后进入投料试生产。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100040676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0196","BK0027","BK0132","BK0077","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525225","title":"和邦生物:不存在规避监管或税务义务的情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666525225?lang=zh_cn&edition=full","pubTime":"2026-09-11 18:18","pubTimestamp":1789121904,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问:贺总减持是直接出售卖入二级市场,还是像以往一样找个自然人在二级市场先接手过去,合理合规合法的规避所得税?和邦生物回复:尊敬的投资者您好,类似问题已回复,请您参考相关回复。公司及相关股东始终遵守法律法规、坚持合规运作,不存在您所猜测的规避监管或税务义务的情形。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100040665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","BK0229","603077","BK0027","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666918665","title":"和邦生物(603077)披露控股股东部分股份解除质押及再质押公告,9月10日股价下跌3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666918665","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666918665?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:06","pubTimestamp":1789049181,"startTime":"0","endTime":"0","summary":"近日,和邦生物发布《关于控股股东部分股份解除质押及部分股份质押的公告》。公告显示,公司控股股东和邦集团持有公司股份1,963,779,103股,占总股本22.24%。截至公告日,和邦集团累计质押股份数量为1,279,000,000股,占其持股总数65.13%,占公司总股本14.48%。近日,和邦集团解除质押218,000,000股,并于同日将相同数量股份重新质押给重庆农村商业银行股份有限公司两江分行,质押融资用于生产经营所需,质押期限至2029年9月8日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000041836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0196","BK0027","BK0229","BK0077","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665448573","title":"异动快报:和邦生物(603077)9月8日10点54分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665448573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665448573?lang=zh_cn&edition=full","pubTime":"2026-09-08 11:00","pubTimestamp":1788836449,"startTime":"0","endTime":"0","summary":"证券之星9月8日盘中消息,10点54分和邦生物(603077)触及涨停板。其所属行业农化制品目前上涨。领涨股为川发龙蟒。该股为草甘膦,磷化工,化肥概念热股,当日草甘膦概念上涨4.62%,磷化工概念上涨4.3%,化肥概念上涨3.92%。9月7日的资金流向数据方面,主力资金净流出26.22万元,占总成交额0.1%,游资资金净流出188.41万元,占总成交额0.69%,散户资金净流入214.63万元,占总成交额0.78%。近5日资金流向一览见下表:和邦生物主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800013146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0196","603077","BK0229","BK0027","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365787","title":"每周股票复盘:和邦生物(603077)为子公司提供2亿元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365787","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365787?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:30","pubTimestamp":1788633033,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,和邦生物报收于2.3元,较上周的2.44元下跌5.74%。本周关注点公司公告汇总:和邦生物为子公司乐山和邦农业提供2亿元连带责任保证担保。截至2026年8月31日,公司及子公司对外担保总额为67.64亿元,占最近一期经审计净资产的37.84%,无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","603077","BK0077","BK0196","BK0229","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664336321","title":"和邦生物(603077)股东四川和邦投资集团有限公司质押2.07亿股,占总股本2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664336321","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664336321?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:28","pubTimestamp":1788517710,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物9月4日公开信息显示,股东四川和邦投资集团有限公司向重庆农村商业银行股份有限公司两江分行合计质押2.07亿股,占总股本2.34%。质押详情见下表:截止本公告日,股东四川和邦投资集团有限公司已累计质押股份12.79亿股,占其持股总数的65.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400035211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","603077","BK0132","BK0027","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664382233","title":"和邦生物:2026年上半年净利润3.80亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664382233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664382233?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:15","pubTimestamp":1788513323,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物09月04日在投资者关系平台上答复投资者关心的问题。公司始终重视全体股东利益,所有股份变动事项均严格遵守证券法律法规及监管规定,并依法履行信息披露义务,不存在干预二级市场股价的情形。公司目前生产经营正常,各项目按计划推进,不存在应披露未披露的重大经营风险。2026年上半年,公司实现归属于母公司股东的净利润3.80亿元,同比增长634.30%,盈利能力显著提高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400030059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385963","title":"和邦生物:公司员工持股计划严格依法依规制定","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664385963?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:03","pubTimestamp":1788512593,"startTime":"0","endTime":"0","summary":"公司员工持股计划严格依法依规制定,经股东会审议通过后实施并依法履行信息披露义务,不存在损害公司及全体股东利益的情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400029662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0027","BK0077","603077","BK0229","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664338561","title":"和邦生物:不存在“机构协议接盘”安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2664338561","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664338561?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:01","pubTimestamp":1788512463,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物09月04日在投资者关系平台上答复投资者关心的问题。投资者提问:回购专户最后减持的1%份额被机构协议接盘的部分,8月31日,9月1日,9月2日,连续三天都在继续减持,才是真正出手了吧?公司减持已回购股份事项均通过集中竞价交易方式实施,交易对手方为不特定市场投资者,不存在您所述的“机构协议接盘”安排。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400029608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","BK0196","BK0077","BK0132","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664845364","title":"股市必读:和邦生物新发布《和邦生物关于提供担保的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845364","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664845364?lang=zh_cn&edition=full","pubTime":"2026-09-03 01:48","pubTimestamp":1788371296,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘,和邦生物报收于2.35元,下跌3.29%,换手率3.55%,成交量313.55万手,成交额7.38亿元。公司公告汇总:和邦生物为全资子公司乐山和邦农业科技有限公司提供2亿元连带责任保证担保,担保期限至2028年8月4日,无反担保。本次担保无反担保,且在公司董事会及股东会授权额度范围内,无需另行审议。截至2026年8月31日,公司及子公司对外担保总额为67.64亿元,占最近一期经审计净资产的37.84%,无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0077","BK0027","BK0132","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857487","title":"和邦生物(603077)披露关于提供担保的进展公告,9月1日股价上涨2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857487","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664857487?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:48","pubTimestamp":1788274095,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,和邦生物报收于2.43元,较前一交易日上涨2.1%,最新总市值为214.61亿元。该股当日开盘2.37元,最高2.49元,最低2.36元,成交额达6.47亿元,换手率为2.99%。近日,和邦生物发布《关于提供担保的进展公告》。本次担保无反担保,且在公司董事会及股东会授权额度范围内,无需另行审议。截至2026年8月31日,公司及子公司对外担保总额为67.64亿元,占最近一期经审计净资产的37.84%,无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0077","BK0132","BK0027","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663718280","title":"和邦生物(603077)披露集中竞价减持已回购股份达1%暨减持结果公告,8月31日股价下跌2.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663718280","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663718280?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:44","pubTimestamp":1788169497,"startTime":"0","endTime":"0","summary":"公司于近日披露《关于集中竞价减持已回购股份达1%暨减持结果公告》。公告显示,四川和邦生物科技股份有限公司于2024年4月至8月期间通过集中竞价交易方式回购股份合计227,027,340股,占公司总股本的2.57%。截至2026年8月28日,公司已通过集中竞价交易方式减持176,630,700股,占公司总股本的2%,减持价格区间为2.40至3.35元/股,出售总金额为478,548,438.97元,减持计划已实施完毕。本次减持后,公司回购专用证券账户持股比例由9.71%降至3.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100024820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","603077","BK0229","BK0027","BK0196","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663078991","title":"和邦生物:公司目前生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663078991?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:33","pubTimestamp":1788161598,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)08月31日在投资者关系平台上答复投资者关心的问题。投资者提问:果然哈,本轮减持剩余1%股份,8月27日还是在2.40附近减持了。一切为了套现?不管什么价格都得卖出去?和邦生物到底有什么重大风险没有披露?和邦生物回复:尊敬的投资者您好,公司回购股份减持计划已实施完毕,相关内容请查阅公司在指定信披网站及媒体披露的相关公告。公司目前生产经营正常,各项目按计划推进,不存在应披露未披露的重大经营风险。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100015512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0132","BK0027","BK0196","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790829449686,"stockEarnings":[{"period":"1week","weight":-0.0267},{"period":"1month","weight":-0.0798},{"period":"3month","weight":-0.0681},{"period":"6month","weight":-0.1859},{"period":"1year","weight":0.0529},{"period":"ytd","weight":-0.031}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川和邦生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"236236人(较上一季度减少14.16%)","perCapita":"37385股","listingDate":"2012-07-31","address":"四川省乐山市五通桥区牛华镇沔坝村","registeredCapital":"883176万元","survey":" 四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是磷矿、盐矿、联碱产品、双甘膦、草甘膦、二乙腈、蛋氨酸、智能玻璃、光伏玻璃及组件、硅片、农药产品,光伏工程建设、天然气管道运输及转供、成品油销售。","listedPrice":17.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和邦生物,603077,和邦生物股票,和邦生物股票老虎,和邦生物股票老虎国际,和邦生物行情,和邦生物股票行情,和邦生物股价,和邦生物股市,和邦生物股票价格,和邦生物股票交易,和邦生物股票购买,和邦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}